Literature DB >> 1337806

Hepatic resection for hepatocellular carcinoma.

M Suenaga1, A Nakao, A Harada, T Nonami, Y Okada, H Sugiura, S Uehara, H Takagi.   

Abstract

One hundred and eighteen patients underwent hepatic resection for hepatocellular carcinoma from 1979 to 1987. Ninety-eight of these patients had co-existing cirrhosis of the liver; 18 patients underwent lobectomy, 28 patients had segmentectomy, and 52 patients had subsegmentectomy. In the 21 non-cirrhotic patients, 11 patients underwent lobectomy, 5 patients had segmentectomy, and 5 patients had subsegmentectomy. The operative mortality rate of patients with cirrhosis was 11% and of patients without cirrhosis was 5%. There was no significant difference in hepatic function tests between survivors and nonsurvivors. Lobectomy of < 55% of the parenchymal hepatic resection rate was well tolerated in the patients with cirrhosis. One-year, 3-year, and 5-year survival rates of patients with hepatocellular carcinoma and co-existing cirrhosis were 57.9%, 36.8% and 20.0% following lobectomy, 82.8%, 82.8% and 57.6% following segmentectomy, and 72.0%, 46.2% and 24.0% following subsegmentectomy. The tumor recurrence rate appeared to be lower after segmentectomy than subsegmentectomy. Multiple gross lesions, tumors > 5 cm, and presence of gross vascular invasion were poor prognostic signs in terms of survival rates as well as recurrence rates. Of the 51 patients with tumor recurrence limited to the residual liver, 13 patients underwent repeat resection, and 23 patients were treated by transcatheter arterial chemoembolization. The survival rates of the patients undergoing repeat resection were significantly better than those of other groups.

Entities:  

Mesh:

Year:  1992        PMID: 1337806     DOI: 10.1007/bf02067120

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ].

Authors:  C COUINAUD
Journal:  Presse Med       Date:  1954-05-05       Impact factor: 1.228

2.  Preoperative estimation of operative risk in liver surgery, with special reference to functional reserve of the remnant liver following major hepatic resection.

Authors:  R Mizumoto; Y Kawarada; T Noguchi
Journal:  Jpn J Surg       Date:  1979-12

3.  Hepatic resection for hepatocellular carcinoma.

Authors:  T Tsuzuki; A Sugioka; M Ueda; S Iida; T Kanai; H Yoshii; K Nakayasu
Journal:  Surgery       Date:  1990-05       Impact factor: 3.982

4.  Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function.

Authors:  E Okamoto; A Kyo; N Yamanaka; N Tanaka; K Kuwata
Journal:  Surgery       Date:  1984-05       Impact factor: 3.982

5.  Estimation of the functional reserve of human liver.

Authors:  F G Moody; L F Rikkers; J S Aldrete
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

6.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

7.  Primary liver cancers in Japan.

Authors: 
Journal:  Cancer       Date:  1980-05-15       Impact factor: 6.860

8.  Liver transplantation for malignant disease. Results in 93 consecutive patients.

Authors:  J G O'Grady; R J Polson; K Rolles; R Y Calne; R Williams
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

9.  Is there a place for liver grafting for malignancy?

Authors:  R Pichlmayr
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

10.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

View more
  8 in total

Review 1.  Therapeutic modalities and prognostic factors for primary and secondary liver tumors.

Authors:  T Lehnert; G Otto; C Herfarth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

2.  Role of surgical treatment for recurrent hepatocellular carcinoma after hepatic resection.

Authors:  Y Nakajima; T Ohmura; J Kimura; T Shimamura; K Misawa; M Matsushita; N Sato; Y Une; J Uchino
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

3.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

4.  Hepatocellular carcinoma in children.

Authors:  S W Moore; P B Hesseling; G Wessels; J W Schneider
Journal:  Pediatr Surg Int       Date:  1997-04       Impact factor: 1.827

Review 5.  Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

Authors:  R Tung-Ping Poon; S T Fan; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

6.  Anterior approach for major right hepatic resection for large hepatocellular carcinoma.

Authors:  C L Liu; S T Fan; C M Lo; R Tung-Ping Poon; J Wong
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

7.  Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma.

Authors:  M Yasui; A Harada; A Torii; A Nakao; T Nonami; H Takagi
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

8.  Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections.

Authors:  H Bismuth; L Chiche; D Castaing
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.